Two deaths and brain tumours: how dangerous is gene therapy?

Following two patient deaths and reports of brain tumours, doctors are debating the safety of gene therapy trials. The core dilemma is balancing patient safety against the urgent need to develop treatments for children with incurable and often worsening conditions. The medical community has yet to reach a consensus on acceptable risk levels.